Capadenoson

DB16118InvestigationalSmall molecule

Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).

Mechanism: Pharmacologically active on Adenosine receptor A1
Curator reviewed
Formula / weight: C₂₅H₁₈ClN₅O₂S₂ · 520.02 g/mol (avg)
Code names: BAY 68-4986

Resolves to

Compound

Structure

InChIKeyCITWCLNVRIKQAF-UHFFFAOYSA-NSMILESNC1=NC(SCC2=CSC(=N2)C2=CC=C(Cl)C=C2)=C(C#N)C(C2=CC=C(OCCO)C=C2)=C1C#N

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Capadenoson, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.